Company IP Overview
Recent StatisticsView All
NewsView All
Pedram Sameni
•
Pedram Sameni
•
Dec 21, 2023
In late August of this year, our ANDA Intelligence 2023 Report was released, a comprehensive study, covering the Hatch-Waxman litigation... Read More
Pedram Sameni
•
Pedram Sameni
•
Nov 9, 2023
In August, our much-anticipated fourth annual ANDA Litigation Intelligence Report made its entrance into the world of pharmaceutical litigation. This... Read More
Pedram Sameni
•
Pedram Sameni
•
Oct 20, 2022
In late August, we published our third annual ANDA Litigation Intelligence Report, covering important statistics and evaluating all stakeholders in... Read More
Recent StatisticsView All
NewsView All
Pedram Sameni
•
Pedram Sameni
•
Dec 21, 2023
In late August of this year, our ANDA Intelligence 2023 Report was released, a comprehensive study, covering the Hatch-Waxman litigation... Read More
Pedram Sameni
•
Pedram Sameni
•
Nov 9, 2023
In August, our much-anticipated fourth annual ANDA Litigation Intelligence Report made its entrance into the world of pharmaceutical litigation. This... Read More
Pedram Sameni
•
Pedram Sameni
•
Oct 20, 2022
In late August, we published our third annual ANDA Litigation Intelligence Report, covering important statistics and evaluating all stakeholders in... Read More